Compare stocks
Evaluate stocks side by side, to find the best fit for your investment goals.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stockPerformance
CumulativeRolling yearsLump sum investment
Invest in $ABBV or Fr.ROP on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.